Michael Cherny
Stock Analyst at Leerink Partners
Total Price Targets
30
Stocks Covered
16
Sectors
Healthcare
Most Recent
Mar 9, 2026
Notable Calls (Last 12 Months)
Most Bullish
Stocks Covered by Michael Cherny
| Symbol | Company | Latest Target | Current Price | Upside | # Targets | Last Updated |
|---|---|---|---|---|---|---|
| CAH | Cardinal Health, Inc. | $275.00 | $195.04 | +41.0% | 4 | Mar 9, 2026 |
| CVS | CVS Health Corporation | $98.00 | $82.34 | +19.0% | 2 | Mar 5, 2026 |
| MCK | McKesson Corporation | $1085.00 | $817.15 | +32.8% | 3 | Mar 5, 2026 |
| GDRX | GoodRx Holdings, Inc. | $3.00 | $2.58 | +16.5% | 1 | Feb 26, 2026 |
| CERT | Certara, Inc. | $10.00 | $6.23 | +60.5% | 1 | Feb 26, 2026 |
| MDLN | Medline Inc. | $56.00 | $44.52 | +25.8% | 1 | Feb 25, 2026 |
| ICLR | ICON Public Limited Company | $105.00 | $112.39 | -6.6% | 3 | Feb 12, 2026 |
| HIMS | Hims & Hers Health, Inc. | $20.00 | $27.22 | -26.5% | 6 | Feb 9, 2026 |
| LH | Labcorp Holdings Inc. | $342.00 | $256.56 | +33.3% | 1 | Oct 28, 2025 |
| HSIC | Henry Schein, Inc. | $75.00 | $74.08 | +1.2% | 1 | Jul 14, 2025 |
| MEDP | Medpace Holdings, Inc. | $330.00 | $417.74 | -21.0% | 1 | Mar 24, 2025 |
| NVST | Envista Holdings Corp | $23.00 | $26.26 | -12.4% | 2 | Oct 31, 2024 |
| ALGN | Align Technology, Inc. | $235.00 | $178.47 | +31.7% | 1 | Oct 24, 2024 |
| DGX | Quest Diagnostics Incorporated | $165.00 | $192.76 | -14.4% | 1 | Oct 23, 2024 |
| PGNY | Progyny, Inc. | $22.00 | $18.64 | +18.1% | 1 | Sep 20, 2024 |
| ACH | Accendra Health, Inc. | $17.00 | $3.73 | +355.8% | 1 | Jun 25, 2024 |
Recent Activity
- Mar 9, 2026— Set$275.00price target onCAH(Cardinal Health, Inc.)
- Mar 5, 2026— Set$1085.00price target onMCK(McKesson Corporation)
- Mar 5, 2026— Set$98.00price target onCVS(CVS Health Corporation)
- Feb 26, 2026— Set$3.00price target onGDRX(GoodRx Holdings, Inc.)
- Feb 26, 2026— Set$10.00price target onCERT(Certara, Inc.)
- Feb 25, 2026— Set$56.00price target onMDLN(Medline Inc.)
- Feb 12, 2026— Set$105.00price target onICLR(ICON Public Limited Company)
- Feb 9, 2026— Set$20.00price target onHIMS(Hims & Hers Health, Inc.)
- Jan 13, 2026— Set$240.00price target onCAH(Cardinal Health, Inc.)
- Dec 4, 2025— Set$41.00price target onHIMS(Hims & Hers Health, Inc.)
- Nov 4, 2025— Set$46.00price target onHIMS(Hims & Hers Health, Inc.)
- Oct 28, 2025— Set$342.00price target onLH(Labcorp Holdings Inc.)
- Aug 12, 2025— Set$186.00price target onCAH(Cardinal Health, Inc.)
- Jul 14, 2025— Set$75.00price target onHSIC(Henry Schein, Inc.)
- Mar 24, 2025— Set$330.00price target onMEDP(Medpace Holdings, Inc.)
- Oct 31, 2024— Set$23.00price target onNVST(Envista Holdings Corp)
- Oct 29, 2024— Set$26.00price target onHIMS(Hims & Hers Health, Inc.)
- Oct 24, 2024— Set$235.00price target onALGN(Align Technology, Inc.)
- Oct 24, 2024— Set$376.00price target onICLR(ICON Public Limited Company)
- Oct 23, 2024— Set$165.00price target onDGX(Quest Diagnostics Incorporated)
Frequently Asked Questions
Who is Michael Cherny?
Michael Cherny is a stock analyst at Leerink Partners covering 16 stocks primarily in Healthcare. They have issued 30 price targets since Aug 5, 2021.
What stocks does Michael Cherny cover?
Michael Cherny currently covers 16 stocks, including HIMS, CAH, MCK, ICLR, CVS.
What is Michael Cherny's latest price target?
Michael Cherny's most recent price target was $275.00 on CAH (Cardinal Health, Inc.), set on Mar 9, 2026.
What is Michael Cherny's highest price target?
Michael Cherny's highest issued price target is $1085.00 on MCK, set on Mar 5, 2026.
More Analysts at Leerink Partners
Coverage based on publicly published price targets. Not investment advice.